These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10664709)

  • 1. Presumed reduction of vestibular function in unilateral Menière's disease with aminoglycoside eardrops.
    Bath AP; Walsh RM; Bance ML
    J Laryngol Otol; 1999 Oct; 113(10):916-8. PubMed ID: 10664709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity and topical eardrops.
    Marais J; Rutka JA
    Clin Otolaryngol Allied Sci; 1998 Aug; 23(4):360-7. PubMed ID: 9762501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intratympanic gentamicin in patients with Ménière's disease: analysis of our protocol].
    Martín Sanz E; Pérez Fernández N
    Acta Otorrinolaringol Esp; 2004; 55(6):270-6. PubMed ID: 15491114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of the vestibular end organs after intratympanic gentamicin failure for Meniere's disease.
    Ishiyama G; Lopez I; Baloh RW; Ishiyama A
    Acta Otolaryngol; 2007 Jan; 127(1):34-40. PubMed ID: 17364327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vestibular results after intratympanic gentamicin therapy in disabling Menière's disease.
    Junet P; Karkas A; Dumas G; Quesada JL; Schmerber S
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3011-8. PubMed ID: 26780342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report.
    Rauch SD; Oas JG
    Laryngoscope; 1997 Jan; 107(1):49-55. PubMed ID: 9001265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity of topical gentamicin preparations.
    Bath AP; Walsh RM; Bance ML; Rutka JA
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1088-93. PubMed ID: 10401847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Menière's disease.
    Nedzelski JM; Schessel DA; Bryce GE; Pfleiderer AG
    Am J Otol; 1992 Jan; 13(1):18-22. PubMed ID: 1598978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single intratympanic gentamicin injection in Ménière's disease: VOR change and prognostic usefulness.
    Marques P; Manrique-Huarte R; Perez-Fernandez N
    Laryngoscope; 2015 Aug; 125(8):1915-20. PubMed ID: 25641686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM; Nedzelski JM; Al-Abidi A; Chen JM; Shipp DB
    J Otolaryngol; 2002 Apr; 31(2):106-11. PubMed ID: 12019738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Degeneration of the Vestibular Efferent Neurons After Intratympanic Gentamicin Administration.
    Wu Q; Zhang Y; Dai C; Kong Y; Pan L
    J Histochem Cytochem; 2018 Nov; 66(11):801-812. PubMed ID: 29762076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intratympanic gentamicin treatment for Meniere's disease cause complete vestibular ablation?
    Hone SW; Nedzelski J; Chen J
    J Otolaryngol; 2000 Apr; 29(2):83-7. PubMed ID: 10819105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.